Taysha Gene Therapies, Inc. TSHA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s common stock?
- Taysha Gene Therapies, Inc. (TSHA) reported common stock of $3K in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s common stock changed year-over-year?
- Taysha Gene Therapies, Inc.'s common stock increased by 50.0% year-over-year, from $2K to $3K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s common stock?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s common stock has grown at a 44.2% compound annual growth rate (CAGR), from $1K to $3K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).